MENU

MRSN Mersana Therapeutics Forecast, Technical & Fundamental Analysis

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRSN is expected to report earnings to fall 55.97% to -15 cents per share on February 26

Mersana Therapeutics MRSN Stock Earnings Reports
Q4'24
Est.
$-0.15
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.05
The last earnings report on November 13 showed earnings per share of -34 cents, missing the estimate of -17 cents. With 3.50M shares outstanding, the current market capitalization sits at 208.77M.
A.I. Advisor
published General Information

General Information

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

MRSN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
-1.93%
CRNX - MRSN
41%
Loosely correlated
+1.35%
MLYS - MRSN
39%
Loosely correlated
+1.56%
VRDN - MRSN
38%
Loosely correlated
-3.34%
IPSC - MRSN
38%
Loosely correlated
N/A
BEAM - MRSN
37%
Loosely correlated
-1.21%
More